As of 4:00pm ET
| +0.02 / +0.29%|
The 5 analysts offering 12-month price forecasts for Arrowhead Pharmaceuticals Inc have a median target of 5.50, with a high estimate of 10.00 and a low estimate of 4.00. The median estimate represents a -21.09% decrease from the last price of 6.97.
The current consensus among 6 polled investment analysts is to Buy stock in Arrowhead Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.